Probiodrug has successfully completed an Initial Public Offering (IPO) and will begin trading on Euronext Amsterdam on Monday 27 October at a share price of €15.25.The flotation raises €22.5 million... Read more
More cystic fibrosis patients in the US should be eligible for treatment with Vertex Pharma's Kalydeco therapy, according to an FDA advisory committee.Yesterday the expert panel voted 13 to two... Read more
Latest Press Releases from the Global Pharma Showcase
London, October 23rd 2014 – Liftstream Ltd, a company providing executive recruitment services to the biotechnology sector, announces the publication of its new free gender diversity report, “Diversifying the Outlook...
Liftstream report finds ten men for every woman present in biotech boardrooms
London, October 23rd 2014 – Liftstream Ltd, a company providing executive recruitment services to the biotechnology sector, announces the publication of its new free gender diversity report, “Diversifying the Outlook – The X&Y of Biotechnology Leadership”, a detailed analysis of women leaders in European and US life biotech companies. The research covers 700 companies, 60 C-level interviews and 530 survey respondents.
The report details how the biotechnology sector is considerably under represented by female executives and Board directors. Female board directors in US & EU Biotech (SMEs) account for only 9.7% and 11.2% of positions respectively, and only 4% of company chairpersons are female. Analysis of large-cap biotech indicated better numbers of female Board members (19.2%) but in terms of female executive leaders (13.9%) it lagged SMEs. Unstructured hiring processes and over-reliance on personal networks among, predominantly male, influencers are identified as underlying causes limiting the opportunities for women in biotech leadership. The research also examines how the sector’s reliance on venture capital financing impacts executive and board appointments, as well as the gender diversity among the VC stakeholder group. The report includes diversity case studies from industry leaders Merck Serono, Cubist, Johnson & Johnson and Biogen Idec.
Key recommendations include:
• CEOs and chairs must lead the change on gender diversity
• Recruiters should provide greater advocacy to companies and women on leadership
• Investors should apply structured process to ensure executive appointments are optimised for diversity
Karl Simpson, CEO at Liftstream commented: “The biotech sector faces considerable challenges in meeting its board and executive leadership requirements. However, this detailed research shows that gender inequality remains a significant problem at the top of companies. Our reported data and examination of influencing factors on the appointment of executives, presents evidence which is designed to help accelerate the opportunities for women to secure vital leadership roles in biotechnology. Improving gender diversity will strengthen leadership teams and lead to better business. At Liftstream we want to provide evidence for leaders to act on and this report improves the sector’s knowledge about gender diversity in biotech leadership.”
Liftstream will be working with their global network of biotechnology and life science executives to develop further initiatives aimed at improving awareness and representation of women leaders in the biotech sector, as well as working with established organisations leading in this area. To download the full free report visit: http://www.liftstream.com/diversity-report.html
Liftstream Ltd is a leader in executive recruitment services for the biotechnology sector; offering our clients a full capability to recruit board and executive leadership, as well as specialised expertise across the functions comprising R&D, Commercial and Operations. Founded in 2003, Liftstream has extensive sector knowledge which we use to advise and support our clients’ hiring requirements and to deliver the highest quality people through a structured and rigorous search process. Liftstream provides services to its clients from London offices. We are supporters of equal opportunities and diversity.
October 20, 2014, NEW YORK, NY – Adult millennials, the coveted 18 to 32-year-old demographic, highly value happiness. However -- according to a new US survey by Allidura Consumer and GSW, both part of inVentiv Health, and Harris Poll -- there appears to be a big tension between the aspirations for happiness – 97% say it’s important -- and the well-documented way millennials are currently living: more stressed, anxious and depressed than any other living generation.[i]
The online survey of 3,530 teens and adults, including 2,015 adult millennials uncovered behaviors and attitudes about health that are unique or consistent across generations. The goal was to better understand today’s health consumers in order to inform and facilitate better interactions with brands.
“As society shifts its focus from relying on HCPs to treat disease to taking individual responsibility for prevention and wellness, we wanted to understand how attuned millennials are to their health now, and how it factors into their everyday decision making,” said Tracy Naden, managing director of Allidura Consumer. “What we learned is that millennials’ mindset about health is very much an ever-present personal journey of wellness fueled by food, exercise and social connections.”
The survey report, “Millennial Mindset: The Worried Well,” notes that as creators of the quantified-self movement, millennials are often perceived as healthier than their Boomer counterparts. Yet, one commonality this generation may not have expected at such an early stage of adulthood is that they worry about their health almost exactly as much as Boomers (77% of both generations say they worry at least a little about getting a serious illness; 77% of adult millennials and 74% of Boomers say they worry at least a little about affording the cost of healthcare). In fact, millennial adults worry about their access to healthcare even more than Boomers (69% vs. 60% worry at least a little).
Health is a Constant State of Mind
The study suggests that millennials see the mind-body connection as important to overall health. With 69% of millennials reporting they stress about their personal health, it seems many are beginning to prioritize mental well-being as a key factor to physical health. In fact, survey results show that 35% of millennials believe seeing a therapist or psychiatrist regularly is important to good health.
Millennials are the first generation to grow up with “doctor Google” at their fingertips. According to Derek Flanzraich, CEO and Founder of Greatist.com, a popular health and wellness website for millennials, “There's never been more health information for millennials to find, so it only make sense that it's never been more difficult for them to properly screen, analyze and act on the right data.” This is supported by survey data that finds 37% of millennials sometimes self-diagnose with health problems that they don’t have. Perpetuating this “search and stress” cycle, 44% say that viewing health information online causes themto worry about their health.
“For millennials, the question isn’t who can help them be healthy, but rather what can help them,” said Leigh Householder, chief innovation officer at GSW. “To millennials, physical health is intricately connected with mental health. So, for brand marketers to be successful in reaching this audience, they must think about health and wellness the same way, and create solutions that inspire millennials to experience health at any given moment and throughout all aspects of their lives.”
To read more about the millennials’ health journey and how brands can reach this health-conscious consumer, download the “Millennial Mindset: The Worried Well” report here.
About the Millennials and Health Study
The millennials and health survey was administered online within the United States between May 21 and June 4, 2014, among 500 US teens ages 13-17 (Millennial teens); 2,015 US adults ages 18-32 (Millennial adults); 508 US adults ages 33-49 (Gen Xers); and 507 US adults ages 50-68 (Baby Boomers). Harris Poll conducted the research.
About Allidura Consumer and GSW, Part of inVentiv Health
Allidura Consumer is a health and wellness communications agency that specializes in creating enduring alliances between brands and those that influence them. The programs and counsel Allidura offers have been tapped by a full range of consumer product companies, including global food and beverage brands, nutritional supplement makers, over-the-counter health and beauty products, and health technology companies. The agency specializes in integrated communications campaigns, corporate reputation management, content strategy and message development, influencer mapping and engagement, media relations and training and social media and employee engagement. You can learn more about Allidura Consumer at www.allidura.com.
GSW is a full-service healthcare communications agency that goes beyond advertising to create personalized brand experiences that involve, inspire, educate and activate people through ongoing brand journeys. MedAd News’ and MM&M’s 2014 Agency of the Year, GSW turns messages into brand experiences that transform people into success stories. Building partnerships with pharmaceutical, biotech and health-and-wellness clients in 18 major markets around the world, GSW creates marketing solutions through a comprehensive and wide array of services including advertising,
digital and closed loop marketing, strategic insight, branding, communications planning, predictive modeling, market access strategies and media and market research. The agency is led by a team of best-in-class marketers who have experience with a variety of stakeholders such as healthcare professionals, patients, caregivers, payors and consumers. For more information, visit http://www.gsw-w.com.
Allidura and GSW are part of inVentiv Health, Inc., a life science knowledge and services company purpose-built for the new healthcare marketplace. inVentiv has created a new model by converging a vast range of essential services to fully align with clients’ development and commercialization goals. For more information, visit www.inVentivHealth.com.
About The Harris Poll
Over the last 5 decades, Harris Polls have become media staples. With comprehensive experience and precise technique in public opinion polling, along with a proven track record of uncovering consumers’ motivations and behaviors, The Harris Poll has gained strong brand recognition around the world. The Harris Poll offers a diverse portfolio of proprietary client solutions to transform relevant insights into actionable foresight for a wide range of industries including health care, technology, public affairs, energy, telecommunications, financial services, insurance, media, retail, restaurant, and consumer packaged goods. Contact Harris Poll for more information.
Clinical Professionals Group Launches Graduate Training Academy
The Clinical Professionals Group is known for their innovation and added value services to Life Sciences and is delighted to announce the launch of their unique Life Sciences Graduate Academy.
With staff turnover in some core roles in clinical drug development at 29% attrition and increasing, Clinical Professionals wanted to take a pro-active role to provide a solution to an ever growing issue. The Life Sciences Graduate Academy is designed to identify, fully fund and train the most talented Life Sciences Graduates.
On completion of the industry leading training program, graduates are deployed into “first to industry” job roles (Clinical Trial Associate / Clinical Research Associate positions). To ensure ease of transition into industry, graduate trainees will have access to a mentor and a continued professional development program to support them during the crucial initial 12 months provided by Clinical Professionals, ensuring no additional strain on a CRO or pharmaceutical organisations’ training departments. The training provided is free of charge to both the client and graduates*.
By taking a pro-active approach to identifying, funding and training high calibre science graduates, the Clinical Professionals’ Graduate Academy will help increase the number of new highly trained professionals entering the life science industry for the first time, therefore having a positive impact on retention by offering a new pool of talented, high quality candidates.
The Graduate Training Academy will provide the option for graduates to progress from a CTA onto a CRA course, if appropriate for the individual, and all successful graduates will receive a retention bonus after 12 months of continuous employment to assist with retention and minimise turnover for the client.
To find out more about Clinical Professionals’ Graduate Academy, please contact a member of our team at email@example.com or visit the link below:
Synergy Vision's Ffyona Dawber is a finalist in the 11th Annual Stevie® Awards for Women in Business
Ffyona Dawber, Managing Director and founder of Synergy Vision, has been selected as a finalist at this year’s 11th Annual Stevie® Awards for Women in Business, in the prestigious categories of “Female Entrepreneur of The Year” and “Woman of The Year.”
The Stevie Awards for Women in Business honour women executives, entrepreneurs, employees and the companies they run – worldwide. The Stevie Awards have been hailed as the world’s premier business awards. Michael Gallagher, founder and president of the Stevie Awards said “The first-round judges have told us how delighted they are with this year’s field of Finalists.” Across all categories, a staggering 1,200 entries were submitted this year for consideration, so it is a significant achievement for Ffyona to be shortlisted in two categories.
Gold, Silver and Bronze Stevie Award winners will be announced during a gala event at the Marriott Marquis Hotel in New York on Friday, November 14. Nominated women executives and entrepreneurs from the U.S.A. and several other countries are expected to attend. The event will be broadcast live on radio in the U.S.A. (and simulcast worldwide) by Biz Talk Radio, and taped for a later television broadcast.
Ffyona established the medical communications agency Synergy Vision in 2007 and has always aimed for success. A former clinical development specialist with many years’ experience in the pharmaceutical industry, Ffyona identified a gap in the market for a full-service medical communications agency that understands first-hand the challenges faced by pharmaceutical clients. “When I created Synergy Vision I wanted trust and good client relationships to be the main focus.” This ethos remains a strong driver of the company’s growth and success.
Sorcha Ferris was one of the first SV team members, who now heads up the Dublin-based sister company SVRx. Sorcha explains why Ffyona’s vision inspired her to join the company, “As a former colleague in the pharma industry, I was inspired by Ffyona’s vision to create an agency with a strong commitment to the client, and was keen to become a part of this unique approach.”
Today, the 30-strong team at Synergy Vision, handpicked for their pharma and agency experience, solid communications know-how, passion for science and events management flair, go the extra mile to deliver the difference to their clients. Synergy Vision strive to become a trusted partner to their clients, and are considered by many to be an extension of their team.
To be a finalist in not just one, but two categories in the Stevie Awards: “Female Entrepreneur of The Year” and “Woman of The Year” reflects Ffyona’s dedication to creating and developing strong and trusted relations, both in-house and with pharma clients, and marks another exciting event in the Synergy Vision calendar!
M3 – the global provider of technology services in healthcare – has scooped the PM Society’s ‘Digital Sales Aid Award’,* for a campaign run in partnership with Rosemont and its agencies - MSA Media and Rainmaker Advertising.
The campaign, which was designed to overcome the common industry marketing problem of limited doctor engagement with pharma-owned websites, generated a 179% increase in sales, year on year, for Rosemont’s liquid formulation of Alendronic acid, for the period of the campaign.
During that period more than 5,000 unique GPs engaged with the Rosemont ImpactZone eDetail on osteoporosiswith each doctor, viewing more than 10 pages and 11% of them viewing all 15 pages of content.
The results were achieved through the use of an M3 developed traffic driving service called ClinAccess, which was launched at the start of 2014 and welcomed Rosemont as its first customer. ClinAccess works via an Application-Programming Interface (API) - a 3rd party web hosting system that provides a seamless link between Doctors.net.uk – the UK’s largest and most active online network of doctors, which is owned by M3 – and a pharma or healthcare company website.
It can cross match doctors against a target list and can be upgraded to provide more detailed information, such as changes in prescribing intentions, following a campaign.
Jan Flynn, Rosemont Marketing Manager, said: ‘Doctors.net.uk surpassed our expectations. Through them, we established a direct relationship with our key GP customers for the first time and saw it directly drive sales - far more cost effectively than if we'd deployed a GP salesforce.’
Dr Tim Ringrose, CEO of M3 (EU) said: ‘This campaign was an exciting collaboration between Rosemont Pharmaceuticals, MSA Media, Rainmaker Advertising and M3. We are thrilled that this digital programme delivered such strong results for Rosemont and we’re delighted the campaign’s success has been rewarded with the PM Society Award.’